LinkChem
Shanghai, China· Est.
Is this your company? Claim your profile to update info and connect with investors.
Claim profilePrivate Company
Funding information not available
Overview
A chemistry-driven biotech offering discovery services and developing proprietary small molecule drugs.
OncologyInfectious Diseases
Technology Platform
A proprietary chemistry and compound library platform focused on the design and synthesis of novel small molecule drug candidates.
Opportunities
Potential to out-license promising preclinical assets to larger pharma companies seeking to bolster their early-stage pipelines.
Risk Factors
The dual service/R&D model may limit resources for proprietary programs, and small molecule discovery carries high attrition risk.
Competitive Landscape
Faces competition from larger CROs in its service business and from well-funded biotechs in its proprietary drug discovery efforts.